Healthcare

Health Care

Our foray into international healthcare reflects our assessment of the long-term potential of this industry. One of the fastest growing business sectors across the world, healthcare is modernising rapidly based on improvements in diagnostic services and medical treatments.

Through our international subsidiary, we have acquired a majority stake in TIASH Pte. Ltd., which itself controls three specialised healthcare services firms - The Iron Suites, TIS-Health and Compai Pharma. The Iron Suites Medical centre is a medical clinic in Singapore, focussed on the management of iron deficiency and the administration of intravenous iron.

We believe a significant market exists for intravenous iron - research suggests that as many as 1 in 3 women of childbearing age may suffer from iron deficiency. TIS-Health provides management services for firms like The Iron Suites and others, including operations, corporate healthcare programmes, and the organisation of medical congresses and awareness programmes, Compai Pharma is focussed on in-licensing pharmaceutical products, and is headquartered in Singapore, with another presence in Malaysia.

Our foray into international healthcare reflects our assessment of the long-term potential of this industry. One of the fastest growing business sectors across the world, healthcare is modernising rapidly based on improvements in diagnostic services and medical treatments.

The first clinic was set up in Singapore where research has found that approximately 1 in 3 women of childbearing age may be unknowingly suffering from iron deficiency. Being a leading centre for the administration of intravenous iron, the clinic focusses on the management of iron deficiency. Geographical expansion of the clinics is being considered presently.
TIS-Health is a consultancy which offers management services for the healthcare industry, which includes but is not limited to the organization of medical events and congresses, operational management of The Iron Suites Medical Centre and the roll-out of disease awareness programs as well as health-related corporate programs.
Headquartered in Singapore and with a presence in Malaysia, the company is specialized in in-licensing and distribution of pharmaceutical products. A Sales and Supply agreement for exclusive distribution of “Monofer” an intravenous iron drug owned by the Danish company Pharmacosmos A/S has been put in place in Malaysia. Sales of Monofer commenced in Malaysia in Nov 2018. The Company employs a specialized team of experienced sales and medical professionals.